NO137497C - Bisfenoksyforbindelser for bruk som utgangsmaterialer ved fremstilling av biskromoner - Google Patents

Bisfenoksyforbindelser for bruk som utgangsmaterialer ved fremstilling av biskromoner

Info

Publication number
NO137497C
NO137497C NO3727/69A NO372769A NO137497C NO 137497 C NO137497 C NO 137497C NO 3727/69 A NO3727/69 A NO 3727/69A NO 372769 A NO372769 A NO 372769A NO 137497 C NO137497 C NO 137497C
Authority
NO
Norway
Prior art keywords
bischromons
initiative
manufacture
materials
bisphenoxy
Prior art date
Application number
NO3727/69A
Other languages
English (en)
Other versions
NO137497B (no
Inventor
Colin Fitzmaurice
Thomas Brian Lee
Roger Edward Colling Altounyan
Original Assignee
Fisons Pharmaceuticals Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE19691918142 external-priority patent/DE1918142A1/de
Priority claimed from DE19691920365 external-priority patent/DE1920365A1/de
Application filed by Fisons Pharmaceuticals Ltd filed Critical Fisons Pharmaceuticals Ltd
Publication of NO137497B publication Critical patent/NO137497B/no
Publication of NO137497C publication Critical patent/NO137497C/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
    • C07D311/22—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4
    • C07D311/24—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4 with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C45/00—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
    • C07C45/61—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups
    • C07C45/67—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton
    • C07C45/673—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton by change of size of the carbon skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C45/00—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
    • C07C45/61—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups
    • C07C45/67—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton
    • C07C45/68—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton by increase in the number of carbon atoms
    • C07C45/70—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton by increase in the number of carbon atoms by reaction with functional groups containing oxygen only in singly bound form
    • C07C45/71—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton by increase in the number of carbon atoms by reaction with functional groups containing oxygen only in singly bound form being hydroxy groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
    • C07D311/06—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 2
    • C07D311/08—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 2 not hydrogenated in the hetero ring
    • C07D311/16—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 2 not hydrogenated in the hetero ring substituted in position 7
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
    • C07D311/22—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pyrane Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Apparatuses For Bulk Treatment Of Fruits And Vegetables And Apparatuses For Preparing Feeds (AREA)
  • Medicinal Preparation (AREA)
NO3727/69A 1965-03-25 1969-09-18 Bisfenoksyforbindelser for bruk som utgangsmaterialer ved fremstilling av biskromoner NO137497C (no)

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
GB12626/65A GB1144905A (en) 1965-03-25 1965-03-25 Substituted bis-(2-carboxy-chromonyl-oxy) derivatives and preparation and pharmaceutical compositions thereof
GB5241465 1965-12-09
GB5374465 1965-12-17
GB37765/68A GB1144906A (en) 1965-03-25 1968-08-07 Bis-phenoxy derivatives
DE19691918142 DE1918142A1 (de) 1969-04-10 1969-04-10 Verfahren zur Herstellung von Bischromonverbindungen
DE19691920365 DE1920365A1 (de) 1969-04-22 1969-04-22 Verfahren zur Herstellung von Bis-Chromonen

Publications (2)

Publication Number Publication Date
NO137497B NO137497B (no) 1977-11-28
NO137497C true NO137497C (no) 1978-03-08

Family

ID=27544127

Family Applications (3)

Application Number Title Priority Date Filing Date
NO162258A NO124875B (no) 1965-03-25 1966-03-23
NO3728/69A NO124832B (no) 1965-03-25 1969-09-18
NO3727/69A NO137497C (no) 1965-03-25 1969-09-18 Bisfenoksyforbindelser for bruk som utgangsmaterialer ved fremstilling av biskromoner

Family Applications Before (2)

Application Number Title Priority Date Filing Date
NO162258A NO124875B (no) 1965-03-25 1966-03-23
NO3728/69A NO124832B (no) 1965-03-25 1969-09-18

Country Status (16)

Country Link
US (2) US3419578A (no)
JP (5) JPS5341662B1 (no)
BE (1) BE678175A (no)
CH (1) CH486445A (no)
DE (1) DE1543579C3 (no)
DK (4) DK134646B (no)
FR (1) FR5452M (no)
GB (2) GB1144905A (no)
IL (1) IL25317A (no)
IT (1) IT1047628B (no)
MY (1) MY7000043A (no)
NL (1) NL147732B (no)
NO (3) NO124875B (no)
OA (1) OA03872A (no)
SE (3) SE355184B (no)
YU (1) YU32999B (no)

Families Citing this family (91)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3862175A (en) * 1965-03-25 1975-01-21 Fison House Bis-chromone compounds
GB1144905A (en) * 1965-03-25 1969-03-12 Fisons Pharmaceuticals Ltd Substituted bis-(2-carboxy-chromonyl-oxy) derivatives and preparation and pharmaceutical compositions thereof
GB1147976A (en) * 1965-12-21 1969-04-10 Fisons Pharmaceuticals Ltd Chromone derivatives
GB1190193A (en) * 1966-07-05 1970-04-29 Fisons Pharmaceuticals Ltd Bis-(2-Carboxy-Chromonyl-Oxy) Derivatives, their preparation, and Pharmaceutical Compositions thereof
US3957965A (en) * 1967-08-08 1976-05-18 Fisons Limited Sodium chromoglycate inhalation medicament
US3860618A (en) * 1967-08-08 1975-01-14 Philip Saxton Hartley Chromone
GB1292601A (en) * 1968-10-30 1972-10-11 Fisons Pharmaceuticals Ltd Bis-(2-carboxy-chromone) compounds, their preparation and pharmaceutical compositions containing them
GB1340512A (en) * 1970-01-21 1973-12-12 Fisons Ltd Production of esters of chromone-2-carboxylic acids
GB1326745A (en) * 1970-04-25 1973-08-15 Fisons Ltd Chromone-2-carboxylic acid derivatives
US3979407A (en) * 1970-07-31 1976-09-07 Allen & Hanburys Limited Chromone derivatives
US4029802A (en) * 1970-08-27 1977-06-14 Fisons Limited The treatment of asthma, hay fever or urticaria
US3933804A (en) 1970-12-14 1976-01-20 Sandoz Ltd., (Sandoz Ag) Insecticidal 1,3-benzodioxol derivatives
US3968235A (en) 1970-12-14 1976-07-06 Sandoz Ltd. Composition and method for combating insects with alkylenedioxyphenyl derivatives
US3965122A (en) * 1970-12-30 1976-06-22 Fujisawa Pharmaceutical Co., Ltd. Chromone compounds and preparation thereof
US4105781A (en) * 1970-12-30 1978-08-08 Fujisawa Pharmaceutical Co., Ltd. Chromone compounds and preparation thereof
GB1399834A (en) * 1971-05-12 1975-07-02 Fisons Ltd Pharmaceutical compositions
US4053628A (en) * 1971-05-12 1977-10-11 Fisons Limited Composition
US3975536A (en) 1971-05-12 1976-08-17 Fisons Limited Composition
GB1384530A (en) * 1971-07-29 1975-02-19 Fisons Ltd Chromone derivatives
US4006245A (en) * 1971-07-29 1977-02-01 Fisons Limited Chemical compounds
GB1410588A (en) * 1971-08-10 1975-10-22 Fisons Ltd Composition
SU469247A3 (ru) * 1972-01-14 1975-04-30 Майлз Лабораториз Инк (Фирма) Способ получени производных хромона
GB1428186A (en) * 1972-06-21 1976-03-17 Fujisawa Pharmaceutical Co Chromone derivatives
FR2196795A1 (en) * 1972-08-25 1974-03-22 Aries Robert Amine salts of bis(carboxychromones) - useful for treatment of dyspnoea and bronchoconstriction
GB1399647A (en) * 1972-12-15 1975-07-02 Fisons Ltd Phenoxyalkoxy-chromone derivatives processes for their preparation and compositions containing them
FR2210398A1 (en) * 1972-12-20 1974-07-12 Aries Robert Bis-(carboxy-chromone) amino ethoxy-ethyl carboxylate salts - useful as a sedative and prophylactic
US3948954A (en) * 1973-01-19 1976-04-06 Fisons Limited Bis-chromone-tetrazole/hydroxamic/carboxylic acids
FR2217004A1 (en) * 1973-02-15 1974-09-06 Aries Robert Sedatives and bronchodilatories - i.e. salts of 1,3-bis(2-carboxychromon-5-yloxy)propanes with 3-hydroxy-2-hydroxymethyl pyridines
FR2230358A2 (en) * 1973-05-25 1974-12-20 Fisons Ltd Cromoglycate contg. solns. - contg. a second therapeutically active cpd. e.g. an antihistamine
US4046910A (en) * 1974-01-28 1977-09-06 The Upjohn Company Dosage schedule
DE2634908A1 (de) * 1974-11-09 1977-04-14 Fisons Ltd Mittel zur behandlung chronischer haut- oder augenerkrankungen
IE41922B1 (en) * 1974-11-09 1980-04-23 Fisons Ltd Pharmaceutical compositions containing bis-chromones
US4161516A (en) * 1975-07-25 1979-07-17 Fisons Limited Composition for treating airway disease
US4067992A (en) * 1975-09-10 1978-01-10 Fisons Limited Method of treating a psychiatric condition
US4145438A (en) * 1975-09-10 1979-03-20 Fisons Limited Method for treatment of eczema or psoriasis
GB1509979A (en) * 1975-11-28 1978-05-10 Fisons Ltd Pharmaceutical compositions containing aspirin or indomethacin
US4097596A (en) * 1976-11-02 1978-06-27 American Home Products Corporation Inhalation therapy for relieving bronchial spasm using quaternary salts of promethazine
GB1557082A (en) * 1977-01-25 1979-12-05 Fisons Ltd Pharmaceutical mixture containing an antiinflammatory
DE2819859A1 (de) * 1977-05-06 1978-11-09 Fisons Ltd Tiermedizinisches behandlungsmittel und inhalationsvorrichtung fuer tiere
US4192860A (en) * 1977-05-06 1980-03-11 Fisons Limited Methods for treating disease conditions
AU522792B2 (en) * 1977-07-19 1982-06-24 Fisons Plc Pressure pack formulation
DE3068213D1 (en) * 1979-09-05 1984-07-19 Glaxo Group Ltd Phenol derivatives, processes for their preparation and pharmaceutical compositions containing them
GB2077100B (en) * 1980-04-30 1985-04-24 Fisons Ltd Pharmaceutical compositions containing cromoglycates
DE3265715D1 (en) 1981-03-24 1985-10-03 Fisons Plc Anti srs-a carboxylic acid derivatives, processes for their production and pharmaceutical formulations containing them
JPS5828509U (ja) * 1981-08-20 1983-02-24 関東電気工事株式会社 分岐箇所用低圧ロ−ラ
US4584315A (en) * 1981-11-16 1986-04-22 The Upjohn Company Method of treating ischemic states
US4447449A (en) * 1981-11-16 1984-05-08 The Upjohn Company Methods of treating ischemic states
US5135940A (en) * 1982-09-23 1992-08-04 Merck Frosst Canada, Inc. Leukotriene antagonists
US4782176A (en) * 1983-01-24 1988-11-01 Hoffmann-La Roche Inc. Phenoxycarboxylic acids
US4581225A (en) * 1984-04-25 1986-04-08 Eli Lilly And Company Sustained release intranasal formulation and method of use thereof
ATE90076T1 (de) 1986-03-27 1993-06-15 Merck Frosst Canada Inc Tetrahydrocarbazole ester.
US4758678A (en) * 1986-07-18 1988-07-19 Pennwalt Corporation Preparation of 7-(2,3-epoxypropoxy)flavone
US5788983A (en) * 1989-04-03 1998-08-04 Rutgers, The State University Of New Jersey Transdermal controlled delivery of pharmaceuticals at variable dosage rates and processes
US5428033A (en) 1990-10-12 1995-06-27 Merck Frosst Canada, Inc. Saturated hydroxyalkylquinoline acids as leukotriene antagonists
US20010003739A1 (en) * 1993-06-24 2001-06-14 Astrazeneca Ab Systemic administration of a therapeutic preparation
US6794357B1 (en) * 1993-06-24 2004-09-21 Astrazeneca Ab Compositions for inhalation
US6632456B1 (en) 1993-06-24 2003-10-14 Astrazeneca Ab Compositions for inhalation
US5830853A (en) 1994-06-23 1998-11-03 Astra Aktiebolag Systemic administration of a therapeutic preparation
GB9317752D0 (en) * 1993-08-26 1993-10-13 Fisons Plc New pharmaceutical use
US5508451A (en) * 1994-07-07 1996-04-16 Hoechst Celanese Corporation Process for the preparation of dialkali metal cromoglycates
US6524557B1 (en) * 1994-12-22 2003-02-25 Astrazeneca Ab Aerosol formulations of peptides and proteins
JP4155594B2 (ja) 1994-12-22 2008-09-24 アストラゼネカ・アクチエボラーグ エアゾール製剤
SE9404468D0 (sv) * 1994-12-22 1994-12-22 Astra Ab Powder formulations
EP1283035A3 (en) * 1994-12-22 2003-03-19 AstraZeneca AB Therapeutic preparation for inhalation containing parathyroid hormone
CA2174583A1 (en) * 1995-05-05 1996-11-06 Alexander Chucholowski Sulfuric acid esters of sugar alcohols
US6150400A (en) * 1997-06-30 2000-11-21 Presutti Laboratories Method for treating vulvar vestibulitis
US6596284B1 (en) 2002-04-30 2003-07-22 Thomas E. Fleming Treating eczema with a combination of isotonic saline ocean® and nasal mast cell stabilizers
US20050026880A1 (en) * 2003-07-31 2005-02-03 Robinson Cynthia B. Combination of dehydroepiandrosterone or dehydroepiandrosterone-sulfate with a cromone for treatment of asthma or chronic obstructive pulmonary disease
US9095621B2 (en) 2008-04-25 2015-08-04 Nektar Therapeutics Oligome-bis-chromonyl compound conjugates
EP3567033A1 (en) * 2009-01-29 2019-11-13 The General Hospital Corporation Cromolyn derivatives and related methods of imaging and treatment
US9925282B2 (en) 2009-01-29 2018-03-27 The General Hospital Corporation Cromolyn derivatives and related methods of imaging and treatment
TR201000733A2 (tr) 2010-02-02 2011-08-22 Bi̇lgi̇ç Mahmut Flutikazon, tiotropyum ve sodyum kromoglikat içeren farmasötik bileşimler.
US20140249180A1 (en) * 2011-10-03 2014-09-04 National Center For Geriatrics And Gerontology Tau aggregation inhibitor
CN104869993B (zh) 2012-10-25 2019-01-15 通用医疗公司 治疗阿尔茨海默病及相关疾病的组合疗法
US10058530B2 (en) 2012-10-25 2018-08-28 The General Hospital Corporation Combination therapies for the treatment of Alzheimer's disease and related disorders
EP2962687B1 (en) 2013-04-02 2019-06-05 The Doshisha Tau aggregation inhibitor
US10525005B2 (en) 2013-05-23 2020-01-07 The General Hospital Corporation Cromolyn compositions and methods thereof
AU2014340182B2 (en) 2013-10-22 2019-05-23 The General Hospital Corporation Cromolyn derivatives and related methods of imaging and treatment
JP2017505348A (ja) 2014-02-10 2017-02-16 パタラ ファーマ リミテッド ライアビリティ カンパニー 肺疾患治療のための肥満細胞安定剤
PL3104853T3 (pl) 2014-02-10 2020-05-18 Respivant Sciences Gmbh Leczenie stabilizatorami komórek tucznych zaburzeń ogólnoustrojowych
US10265296B2 (en) 2015-08-07 2019-04-23 Respivant Sciences Gmbh Methods for the treatment of systemic disorders treatable with mast cell stabilizers, including mast cell related disorders
WO2017027387A1 (en) 2015-08-07 2017-02-16 Patara Pharma, LLC Methods for the treatment of mast cell related disorders with mast cell stabilizers
JP2019528320A (ja) 2016-08-31 2019-10-10 レシュピファント サイエンシス ゲゼルシャフト ミット ベシュレンクター ハフトゥングＲｅｓｐｉｖａｎｔ Ｓｃｉｅｎｃｅｓ Ｇｍｂｈ 特発性肺線維症による慢性咳の治療のためのクロモリン組成物
US20190240194A1 (en) 2016-08-31 2019-08-08 The General Hospital Corporation Macrophages/microglia in neuro-inflammation associated with neurodegenerative diseases
EP3522983A4 (en) 2016-10-07 2020-06-03 Respivant Sciences GmbH CROMOLYN COMPOSITION FOR TREATING LUNG FIBROSIS
CN111565711B (zh) 2017-07-20 2023-01-03 阿茨治疗股份有限公司 色甘酸钠和布洛芬的粉末化制剂
KR20210071943A (ko) 2018-07-02 2021-06-16 더 제너럴 하스피탈 코포레이션 크로몰린 소듐 및 α-락토스의 분말화된 제형
US12383528B2 (en) 2018-12-10 2025-08-12 The General Hospital Corporation Cromolyn esters and uses thereof
WO2021094296A1 (en) 2019-11-12 2021-05-20 INSERM (Institut National de la Santé et de la Recherche Médicale) Use of mast cell stabilizer for the treatment of heart failure with preserved ejection fraction
WO2021207060A1 (en) 2020-04-06 2021-10-14 The General Hospital Corporation Methods of treatment of coronavirus-induced inflammation conditions
US12612391B2 (en) 2020-12-28 2026-04-28 The General Hospital Corporation Cromolyn derivatives and uses thereof

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2769015A (en) * 1954-10-06 1956-10-30 Lab Laroche Navarron Process of preparing 3-methyl-chromone
US3162673A (en) * 1960-12-28 1964-12-22 Union Carbide Corp Bis (aminoaliphatic) carbonates and process for preparation
GB1144905A (en) * 1965-03-25 1969-03-12 Fisons Pharmaceuticals Ltd Substituted bis-(2-carboxy-chromonyl-oxy) derivatives and preparation and pharmaceutical compositions thereof

Also Published As

Publication number Publication date
NL6603997A (no) 1966-09-26
YU177066A (en) 1975-08-31
JPS5343492B1 (no) 1978-11-20
SE371185B (no) 1974-11-11
US3419578A (en) 1968-12-31
DK128353B (da) 1974-04-16
SE355184B (no) 1973-04-09
GB1144906A (en) 1969-03-12
DE1543579B2 (de) 1980-01-03
JPS5341662B1 (no) 1978-11-06
NL147732B (nl) 1975-11-17
DK134646C (no) 1977-05-16
FR5452M (no) 1967-10-16
BE678175A (no) 1966-09-21
DK128245B (da) 1974-03-25
JPS5341663B1 (no) 1978-11-06
NO137497B (no) 1977-11-28
DK134646B (da) 1976-12-13
OA03872A (fr) 1971-12-24
NO124832B (no) 1972-06-12
DE1543579C3 (de) 1980-08-28
IL25317A (en) 1970-08-19
DK128318B (da) 1974-04-08
YU32999B (en) 1976-03-31
JPS5343493B1 (no) 1978-11-20
MY7000043A (en) 1970-12-31
DE1543579A1 (de) 1969-11-06
GB1144905A (en) 1969-03-12
CH486445A (fr) 1970-02-28
IT1047628B (it) 1980-10-20
US3671625A (en) 1972-06-20
NO124875B (no) 1972-06-19
JPS4843506B1 (no) 1973-12-19
SE372941B (no) 1975-01-20

Similar Documents

Publication Publication Date Title
NO784144L (no) Forbindelser egnet for bruk ved fremstilling av alfa-aminobenzylpenicilliner
BE668295A (fr) Perfectionnements à la production de matières poreuses
AT277795B (de) Überzogenes Schleifmittelprodukt
FR1500499A (fr) Polymères du type carbamoyl-cationique
SE343292B (sv) Foerfarande foer framstaellning av vissa angivna bensofenoniminer
IT1052974B (it) Materiali polimerizzabili
SE380590B (sv) Sjelvforankrande skruv
NO136299C (no) Alkoholer for anvendelse som utgangsmaterialer for fremstilling av insekticide estere
FI41452C (fi) Av konstämne tillverkad dekorationsplatta
AU406481B2 (en) Production of honeycomb materials
CA683032A (en) Honeycomb materials
AU422263B2 (en) Process for the manufacture of pre impregnated webs
CA722676A (en) Manufacture of new guanidines
FI48094C (fi) Menetelmä bakteerinvastaisesti vaikuttavien bentseenisulfonyyli-2-amin o-delta-2-tiatsoliinien valmistamiseksi
BR6683857D0 (pt) Processos para a preparacao de a nor-3-gonenos
FI36028A (fi) Kylpyhuoneisiin ja senkaltaisiin tarkoitettu kuivausteline
AU4633764A (en) Production of honeycomb materials
AU4825464A (en) Production of honeycomb materials
CA674000A (en) Honeycomb materials
CA706442A (en) Manufacture of expanded materials
BR6683923D0 (pt) Novos compostos de 6-alfa-metil-estreno
AU588066A (en) Process for the manufacture of pre impregnated webs
CA710401A (en) Manufacture of polymeric materials
AU405226B2 (en) Regeneration of ion-exchange materials
FI43721C (fi) Menetelmä 7-kloori-6-demetyylitetrasykliinin valmistamiseksi